Effects of sodium nitroprusside on renal functions and NO-cGMP production in anesthetized dogs

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 3, 1999, Pages 401-408

  Tanahashi, Masayuki ^a   Sekizawa, Toshihiro ^a   Yoshida, Makoto ^a   Suzuki Kusaba, Mizue ^a   Hisa, Hiroaki ^a   Satoh, Susumu ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Cyclic GMP Kidney; Nitric oxide; Sodium nitroprusside

Indexed keywords

CYCLIC GMP; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG ACTIVITY; FEMALE; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY; KIDNEY DENERVATION; KIDNEY FUNCTION TEST; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL;

ANESTHESIA; ANIMALS; BLOOD PRESSURE; CYCLIC AMP; DOGS; FEMALE; GLOMERULAR FILTRATION RATE; HEART RATE; INFUSIONS, INTRA-ARTERIAL; KIDNEY; KIDNEY FUNCTION TESTS; MALE; NITRIC OXIDE; NITROPRUSSIDE; OSMOLAR CONCENTRATION; RENAL ARTERY; RENAL CIRCULATION; SODIUM; TRIAZENES; URODYNAMICS; VASCULAR RESISTANCE; VASODILATOR AGENTS; WATER;

EID: 0033030259     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199903000-00009     Document Type: Article

References (23)

1. Ignarro LJ. Nitric oxide. A novel signal transduction mechanism for transcellular communication. Hypertension 1990;16:477-83.
2. Waldman SA, Murad F. Cyclic GMP synthesis and function. Pharmacol Rev 1987;39:163-96.
3. Zeidel ML. Hormonal regulation of inner medullary collecting duct sodium transport. Am J Physiol 1993;265:F159-73.
4. Tsuchiya K, Sanaka T, Ando A, Sugino N. Effects of atrial natriuretic peptide on regional renal blood flow measured by a thermal diffusion technique. Jpn J Exp Med 1989;59:27-35.
5. Feelisch M, Kelm M. Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle and endothelial cells. Biochem Biophys Res Commun 1991;180:286-93.
6. Anderson TJ, Meredith IT, Granz P, Selwyn AP, Yeung AC. Nitric oxide and nitrovasodilators: similarities, differences and potential interactions. J Am Coll Cardiol 1994;24:555-66.
7. Helen BL, Ram S, Jing ZL, Virginia JS. Sodium nitroprusside increases glomerular capillary hydraulic conductivity in isolated rat glomeruli. J Lab Clin Med 1995;125:450-5.
8. Roczniak A, Burns KD. Nitric oxide stimulates guanylate cyclase and regulates sodium transport in rabbit proximal tubule. Am J Physiol 1996;270:F106-15.
9. Süto T, Losonczy G, Qiu C, et al. Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production. Kidney Int 1995;48:1272-7.
10. Baylis C, Masilamani S, Losonczy G, Samsell L, Harton P, Engels K. Blood Pressure (BP) and renal vasoconstrictor responses to acute blockade of nitric oxide: persistence of renal vasoconstriction despite normalization of BP with either verapamil or sodium nitroprusside. J Pharmacol Exp Ther 1995;274:1135-41.
11. Grandes S, Gallego MJ, Riesco A, et al. Mechanisms of renal effects of different agents stimulating production of cGMP. Am J Physiol 1991;261:H1109-14.
12. Maekawa H, Matsumura Y, Matsuo G, Morimoto S. Effect of sodium nitroprusside on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs. J Cardiovasc Pharmacol 1996;27:211-7.
13. Davidson WD, Sackner MA. Simplification of the anthrone method for the determination of inulin in clearance studies. J Lab Clin Med 1963;62:351-6.
14. Shepherd AM, Pinkley W, Lin MS, McNay JL, Keeton TK. Activation of the renin-angiotensin system by sodium nitroprusside in essential hypertension. J Cardiovasc Pharmacol 1984;6: 201-5.
15. Shepherd AM, Irvine NA. Differential hemodynamic and sympathoadrenal effects of sodium nitroprusside and hydralazine in hypertensive subjects. J Cardiovasc Pharmacol 1986;8:527-33.
16. Suzuki S, Takeshita A, Imaizumi T, Yoshida M, Ando S, Nakamura M. Biphasic forearm vascular responses to intraarterial arginine vasopressin. J Clin Invest 1989;84:427-34.
17. Hisa H, Araki S, Tomura Y, Hayashi Y, Satoh S. Effects of alpha adrenoceptor blockade on renal nerve stimulation-induced norepinephrine release and vasoconstriction in the dog kidney. J Pharmacol Exp Ther 1989;248:752-7.
18. Tomura Y, Yamagata T, Hisa H, Satoh S. Effects of atrial natriuretic peptide on adrenergically induced norepinephrine release and vasoconstriction in the dog kidney. Eur J Pharmacol 1991;199:255-8.
19. Stoos BA, Garcia NH, Garvin JL. Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol 1995;6:89-94.
20. Scavone C, Scanlon C, McKee M, Nathanson JA. Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase. J Pharmacol Exp Ther 1995;272:1036-43.
21. Kiedrowski L, Manev H, Costa E, Wroblewski JT. Inhibition of glutamate-induced cell death by sodium nitroprusside is not mediated by nitric oxide. Neuropharmacology 1991;30:1241-3.
22. Bohn H, Schnafinger K. Oxygen and oxidation promote the release of nitric oxide from sydnonimines. J Cardiovasc Pharmacol 1989; 14(suppl 11):S6-12.
23. Hrabie JA, Klose JR, Wink DA, Keefer LK. New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem 1993;59: 1472-6.